Home / Nieuws / ...

Gebruik van pijnstiller bij tieners vergroot duidelijk de kans op astma *
Het gebruik van de pijnstiller paracetamol door tieners blijkt volgens een Nieuw Zeelandse studie de kans op astma, allergische rinitis en eczeem flink te verhogen. In de studie werden wereldwijd 300.000 tieners van 13-14 jaar bekeken. Zij die het jaar daarvoor slechts 1 keer paracetamol gebruikt hadden bleken 43% meer kans te hebben op astma, 38% meer kans op allergische rinitis en 31% meer kans op eczeem. Zij die een of meer keer per maand paracetamol gebruikten hadden 251% meer kans op astma, 239% op allergische rinitis en 100% meer kans op eczeem.
Acetaminophen more than doubles risk of asthma in young people
Acetaminophen, the active ingredient in Tylenol and other common painkillers, is under fire after a new study revealed that the drug can significantly increase young people's risk of developing asthma and eczema. According to the report published in the American Journal of Respiratory and Critical Care Medicine, adolescents who take acetaminophen just once a month have a doubled risk of developing asthma compared to children who do not take the drug.
"This study has identified that the reported use of acetaminophen in 13- and 14-year old adolescent children was associated with an exposure-dependent increased risk of asthma symptoms," explained Richard Beasley, M.D., professor of medicine at the Medical Research Institute of New Zealand and author of the study.
Even children who only take acetaminophen once a year have a 50 percent increased risk of developing asthma, illustrating that even very minute doses of the drug taken infrequently can cause severe respiratory problems.
For the study, researchers evaluated 300,000 13- and 14-year old children from around the world and found that those who took acetaminophen at least once during the previous year had a 43 percent increased risk of developing asthma, a 38 percent increased risk of developing rhinoconjunctivitis, also known as allergic nasal congestion, and a 31 percent increased risk of developing eczema, compared to non-users.
"High" users who took the drug at least once in the month prior to the study had a 251 percent increased risk of developing asthma, a 239 percent increased risk of developing rhinoconjunctivitis, and a nearly 100 percent increased risk of developing eczema, compared to non-users. (December 2010)